Afrigen Biologics and Vaccines is a South African biotechnology company focused on the research, development, and manufacturing of vaccines and biopharmaceutical products. The organisation is known for its work in advancing vaccine technology, particularly in areas such as mRNA platform development and local vaccine production capability. Afrigen plays a significant role in strengthening Africa’s capacity to produce vaccines independently, reducing reliance on imported medical products and improving access to life saving immunisations.
The company collaborates with international health organisations, research institutions, and governments to support innovation in vaccine science and public health solutions. Afrigen Biologics and Vaccines is also involved in training scientists and building technical expertise within the biotechnology sector. Through its research driven approach and commitment to health equity, the organisation contributes to the development of sustainable healthcare solutions for South Africa and the broader African continent.